Market requirements · AT
Austria
BASG has published a dedicated position holding that a research-use label does not change a peptide's classification. Import and placing on the market follow from that classification.
Buyers in this market search for: Peptide Grosshandel, Peptide legal Oesterreich.
| Tell us the compounds you need for Austria. | Ask about Austria |
The regime
How compounds are classified in Austria
| Governing law and regulator | Austria applies EU medicines law through the Arzneimittelgesetz (AMG). The Bundesamt fuer Sicherheit im Gesundheitswesen (BASG), operating under AGES, is the competent authority for licensing, market surveillance and enforcement of human medicines, including online and imported products. |
|---|---|
| Research-label position | BASG has published a dedicated statement holding that a research-use, research-grade or laboratory-only label on a peptide is legally irrelevant. Products are classified by BASG as unlicensed medicines based on active ingredient, concentration, effect and available scientific data, not by seller-supplied packaging language. |
| Import and marketing ban | Once BASG classifies a peptide as an unlicensed medicine, placing it on the market in Austria and importing it into Austria are both prohibited. Legal consequences fall on distributors and importers, and BASG explicitly warns that buyers themselves can also face consequences such as referral to authorities. |
| GLP-1 class | In a notice dated 4 September 2025 citing a joint EMA/HMA warning, BASG confirmed GLP-1 receptor agonists such as semaglutide, liraglutide and tirzepatide are prescription-only medicines for obesity and diabetes. Online sale of prescription medicines is banned in Austria, and fake listings misuse the BASG logo. |
| Prescription compounds and wholesale route | Somatropin and hCG/HMG-class gonadotropins appear as registered prescription medicines in Austria's own medicines database. Legal wholesale import and resale requires a Grosshandelsbetriebsbewilligung under section 63 AMG, issued by BASG and listed on its public register of authorised wholesale businesses. |
| Already supplying Austria? Send the compounds and volumes you buy today and we will quote against them. | Send your list |
Your obligations
What a buyer in Austria needs settled
- Hold a Grosshandelsbetriebsbewilligung (section 63 AMG wholesale licence) from BASG before importing or reselling any of these compounds.
- Do not rely on a research-use or research-grade label; BASG regards that framing as legally irrelevant and classifies the product as an unlicensed medicine on ingredient and effect.
- Assume GLP-1, somatropin, gonadotropin and Melanotan-class peptides is prescription medicines; online sale of prescription medicines is banned outright in Austria.
- Expect enforcement contact through BASG's enforcement@basg.gv.at channel; both importers and buyers of unlicensed peptides face legal exposure.
We will ask about this at enquiry. We check the authorisations your activity requires before quoting, and we confirm the position per compound rather than for the market as a whole.
Sources
Check this yourself
Every position above traces to a dated public document. The authority, the document, the date and the link are below.
| Authority and document | Date | Link |
|---|---|---|
| BASG Peptide - Illegale Praeparate aus dem Internet mit unkalkulierbarem Gesundheitsrisiko | 2026-05-27 | www.basg.gv.at/marktbeobachtung/amtliche-nachrichten/detai... |
| BASG Starker Anstieg illegaler Arzneimittel in der EU - Warnung vor gefaelschten GLP-1-Rezeptoragonisten | 2025-09-04 | www.basg.gv.at/marktbeobachtung/amtliche-nachrichten/detai... |
| BASG Arzneimittelbetriebe - public register of section 63/63a AMG wholesale authorisation holders | undated | www.basg.gv.at/marktbeobachtung/oeffentliche-register/arzn... |
Links go to the issuing body wherever one exists. Positions change. If you are relying on any of this, check the source rather than this page.
Market brief
Take the Austria brief as a PDF
The regime, the buyer obligations and all 3 sources, dated and linked, in one document you can forward.
Nearby
German-speaking markets and nearby markets
Buyers supplying one of these usually supply the others. The requirements are not the same.
| Code | Market | Sources | |
|---|---|---|---|
| DE | Germany | 2 sources | Germany applies the Arzneimittelgesetz alongside anti-doping legislation, and ... |
| CH | Switzerland | 5 sources | Swissmedic regulates therapeutic products under the Heilmittelgesetz and runs ... |
| BE | Belgium | 3 sources | Belgium applies EU medicines law through the FAGG, which has published a GLP-1... |
Scope
How to use this page
A summary of the published regulatory position in Austria as at 2026-08-20, written for procurement teams deciding how to source. Every source is dated and linked so it can be checked at origin.
It is not legal advice. Full terms of supply, including where responsibility sits, are set out in our terms of supply.
Questions
Supplying into Austria
Do you supply into Austria?
We supply businesses that hold the authorisations their activity requires. Whether a specific compound can be supplied into Austria depends on that compound and on your authorisations, and we confirm it per compound at the enquiry stage.
Who carries the compliance obligation?
The importer of record and the party placing the product on the market, which is the buyer. We supply the batch documentation that supports your file. We cannot hold your authorisations for you.
How current is this page?
It was reviewed on 2026-08-20 and is scheduled for review again on 2026-11-18. Every source is dated and linked, so you can check the original.
We already supply into Austria. What changes if we source from you?
The batch documentation. You receive a Certificate of Analysis per batch, which can be issued under your own brand. The import and market-placing responsibilities stay where they are.
Is this legal advice?
No. It is a summary of the regulatory positions those authorities have published, as at the review date above. Take advice in your own market before you rely on it.
Enquire about supply into Austria
Tell us the compounds and your authorisations. We confirm per compound before anything ships.